ATLANTA, Aug 16. -- Sciele Pharma, Inc. today announced that the U.S. Food & Drug Administration (FDA) has accepted the New Drug Application (NDA) submitted by Summers Laboratories for a head lice ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback